[1] 张彦兵,王妍华,郭亚焕,等.miR-135b促进肝癌细胞侵袭和转移[J].细胞与分子免疫学杂志,2015,31(10):1316-1321.
[2] QADIR M I,FAHEEM A.miRNA:A diagnostic and therapeutic tool for pancreatic cancer[J].Crit Rev Eukaryot Gene Expr,2017,27(3):197-204.
[3] 曹晶珠,郑浩,陶元平,等.miR-509-3p在肝癌组织中的表达及对肝癌细胞迁移侵袭的影响[J].中国癌症杂志,2018,28(12):888-894.
[4] 黄仕灵.miR-210在肝癌组织中的表达及与手术患者预后的相关性[J].现代诊断与治疗,2017,28(7):1314-1315.
[5] 辛志泳,谢爽.miR-210在肝癌中的异常表达及其与预后的相关性[J].现代肿瘤医学,2016,24(13):2104-2106.
[6] 曾智,阎红琳,陈龙艳,等.结直肠腺癌组织中USP10的表达及生物信息学分析[J].临床与实验病理学杂志,2017,33(10):1063-1069.
[7] LU C,NING Z,WANG A,et al.USP10 suppresses tumor progression by inhibiting mTOR activation in hepatocellular carcinoma[J].Cancer Lett,2018,436(1):139-148.
[8] 赵立涵,刘立,蒋波,等.MicroRNA-144-3p对肝癌细胞增殖、侵袭转移的影响及其机制[J].临床和实验医学杂志,2018,17(14):1493-1496.
[9] 赵延兵,张玮,赵巧云,等.miR-181-5p通过下调AKT3通过下调AKT3抑制肝癌细胞侵袭和转移[J].河南科技大学学报(医学版),2018,36(1):15-18.
[10] 王勇强,吴林波,陈帆.miR-10b对肝癌细胞增殖、侵袭和迁移的影响[J].中国医药导报,2016,13(34):25-29.
[11] 邱峰,费建平,陆艺,等.miR-26a对肝癌细胞侵袭迁移能力的影响及初步机制的研究[J].现代肿瘤医学,2016,24(6):878-881.
[12] REN D,YANG Q,DAI Y,et al.Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway[J].Mol Cancer,2017,16(1):117-127.
[13] REN J,LI X,DONG H,et al.miR-210-3p regulates the proliferation and apoptosis of non-small cell lung cancer cells by targeting SIN3A[J].Exp Ther Med,2019,18(4):2565-2573.
[14] WITLIK W Z,KARBOWNIK M S,SUWALSKI M,et al.Serum miR-210-3p as a potential noninvasive biomarker of lung adenocarcinoma:a preliminary study[J].Genet Test Mol Biomarkers,2019,23(5):353-358.
[15] 梁治坤,程几天,胡走肖,等.miR-150-5p抑制肝癌细胞的迁移和侵袭及其机制[J].中国普通外科杂志,2016,25(8):1175-1179.
[16] SUN J,LI T,ZHAO Y,et al.USP10 inhibits lung cancer cell growth and invasion by upregulating PTEN[J].Mol Cell Biochem,2018,441(1-2):1-7.
[17] ZENG Z,LI D,YU T,et al.Association and clinical implication of the USP10 and MSH2 proteins in non-small cell lung cancer[J].Oncol Lett,2019,17(1):1128-1138.
[18] OUYANG S W,LIU T T,LIU X S,et al.USP10 regulates Musashi-2 stability via deubiquitination and promotes tumour proliferation in colon cancer[J].FEBS Lett,2019,593(4):406-413. |